Can type 1 diabetes be prevented or reversed?
作者信息
Bloomgarden Zachary
机构信息
Department of Medicine, Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
出版信息
J Diabetes. 2024 May;16(5):e13572. doi: 10.1111/1753-0407.13572.
Abstract
摘要
相似文献
1
Can type 1 diabetes be prevented or reversed?
J Diabetes. 2024 May;16(5):e13572. doi: 10.1111/1753-0407.13572.
2
The role of vitamin D in protecting type 1 diabetes mellitus.
Diabetes Metab Res Rev. 2005 Jul-Aug;21(4):338-46. doi: 10.1002/dmrr.557.
3
[Can type 1 diabetes mellitus be prevented?].
Duodecim. 1994;110(10):928-31.
4
[Can insulin-dependent diabetes be cured or prevented?].
Rev Prat. 1992 Jan 15;42(2):199-200.
5
[Can type 1 diabetes be prevented?].
Tidsskr Nor Laegeforen. 1992 Sep 30;112(23):2951-2.
6
[Can mitochondrial diabetes mellitus and myopathies be prevented?].
Neurologia. 1999 Jun-Jul;14(6):319-20.
7
[Can type 1 diabetes be prevented?].
MMW Fortschr Med. 2004 Nov 25;146(48):14.
8
Can we prevent type 1 diabetes?
J La State Med Soc. 2000 Jun;152(6):286-8.
9
[Vaccination against type 1 diabetes at the clinical trial stage].
Lakartidningen. 1999 Mar 17;96(11):1300-2.
10
Prevention of type 1A diabetes mellitus.
Endocr Pract. 2012 Sep-Oct;18(5):745-9. doi: 10.4158/EP12080.OR.
本文引用的文献
1
Endpoints for clinical trials in type 1 diabetes drug development.
Lancet Diabetes Endocrinol. 2024 May;12(5):297-299. doi: 10.1016/S2213-8587(24)00097-4.
2
The opportunities and challenges of the disease-modifying immunotherapy for type 1 diabetes: A systematic review and meta-analysis.
Pharmacol Res. 2024 May;203:107157. doi: 10.1016/j.phrs.2024.107157. Epub 2024 Mar 24.
3
Immune checkpoint modulators in early clinical development for the treatment of type 1 diabetes.
Expert Opin Investig Drugs. 2024 Apr;33(4):303-318. doi: 10.1080/13543784.2024.2326036. Epub 2024 Mar 13.
4
Chimeric Antigen Receptor (CAR)-Based Cell Therapy for Type 1 Diabetes Mellitus (T1DM); Current Progress and Future Approaches.
Stem Cell Rev Rep. 2024 Apr;20(3):585-600. doi: 10.1007/s12015-023-10668-1. Epub 2023 Dec 28.
5
Baricitinib and β-Cell Function in Patients with New-Onset Type 1 Diabetes.
N Engl J Med. 2023 Dec 7;389(23):2140-2150. doi: 10.1056/NEJMoa2306691.
6
Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes.
N Engl J Med. 2023 Dec 7;389(23):2151-2161. doi: 10.1056/NEJMoa2308743. Epub 2023 Oct 18.
7
Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic review.
Commun Med (Lond). 2023 Oct 5;3(1):130. doi: 10.1038/s43856-023-00357-y.
8
Anti-CD3 monoclonal antibodies in treatment of type 1 diabetes: a systematic review and meta-analysis.
Endocrine. 2024 Feb;83(2):322-329. doi: 10.1007/s12020-023-03499-0. Epub 2023 Sep 1.
9
Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial.
JAMA. 2023 Mar 28;329(12):990-999. doi: 10.1001/jama.2023.2064.
10
Epitope-based precision immunotherapy of Type 1 diabetes.
Hum Vaccin Immunother. 2023 Dec 31;19(1):2154098. doi: 10.1080/21645515.2022.2154098. Epub 2023 Jan 19.
Zotero 插件